N-terminally acetylated Leu-enkephalin is the N-terminally acetylated form of Leu-enkephalin. Leu-enkephalin is a five amino acid endogenous peptide that acts as an agonist at opioid receptors.
N-terminally acetylated Leu-enkephalin is a synthetic peptide derivative structurally based on the endogenous opioid pentapeptide Leu-enkephalin, with an acetyl group introduced at the N-terminus. This chemical modification confers increased metabolic stability and alters its interaction profile with peptidases and opioid receptors, making it a valuable tool in neurochemical and pharmacological research. The peptide's sequence and acetylation pattern are of notable interest for studies exploring opioid receptor selectivity, peptide degradation pathways, and the design of bioactive neuropeptide analogs. As a research reagent, it is widely utilized in experimental models to dissect the structure-activity relationships governing opioid peptide function and to probe the physiological roles of enkephalinergic signaling.
Receptor binding studies: N-terminally acetylated Leu-enkephalin is extensively employed in receptor binding assays to investigate the affinity and selectivity of opioid peptides for μ and δ opioid receptors. The acetylation at the N-terminus can significantly influence receptor interaction dynamics, providing insights into how chemical modifications affect peptide-receptor recognition. Researchers utilize this analog to map binding sites, characterize receptor subtypes, and assess the impact of structural changes on ligand efficacy, contributing to a deeper understanding of opioid pharmacology and receptor activation mechanisms.
Peptide stability assessments: The acetylated analog is particularly useful in investigations focused on peptide degradation and metabolic stability. By comparing its enzymatic resistance to that of unmodified Leu-enkephalin, scientists can elucidate the role of N-terminal modifications in extending peptide half-life in biological matrices. Such studies are crucial for understanding the metabolic fate of neuropeptides, optimizing peptide-based drug candidates, and developing more stable research tools for in vitro and in vivo applications.
Structure-activity relationship research: In the context of SAR studies, N-terminally acetylated Leu-enkephalin serves as a model compound to dissect how specific chemical modifications at the peptide's termini influence biological activity. Researchers systematically evaluate the functional consequences of acetylation on receptor potency, selectivity, and downstream signaling. These findings are instrumental in guiding the rational design of novel opioid peptide analogs with tailored pharmacological profiles for basic research and drug discovery efforts.
Neuropeptide signaling pathway analysis: The compound is frequently utilized to probe enkephalinergic signaling pathways in neuronal and non-neuronal systems. Its enhanced stability and altered receptor interactions make it a preferred tool for delineating the physiological and biochemical roles of enkephalins in modulating neurotransmission, pain processing, and cellular signaling cascades. By employing this acetylated peptide in cellular assays and tissue preparations, researchers can more accurately assess the functional outcomes of enkephalinergic activation and inhibition under controlled experimental conditions.
Analytical reference standard: N-terminally acetylated Leu-enkephalin is also applied as a reference standard in analytical chemistry, particularly in the development and validation of chromatographic or mass spectrometric methods for peptide quantification. Its defined structure and physicochemical properties facilitate method calibration, quality control, and comparative analysis of peptide samples in complex biological matrices. The availability of this acetylated analog enhances the reliability and reproducibility of analytical workflows in neuropeptide research and biomarker discovery.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More